Quest Diagnostics Launches Consumer-Facing AI on Its App and Portal
The company’s patients can use AI to look at trends going back five years
Already a member? Log in here
Testing Trends-dtet
GRAIL’s Moves with MCED Test Illustrate Direct-to-Consumer Surge
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement
Already a member? Log in here
GNPC identifies subset of proteins elevated across Alzheimer’s and Parkinson’s
Consortium hosts large proteomics dataset for neurodegenerative diseases
Already a member? Log in here
Child-Parent Cholesterol Screening Found Effective
From – Diagnostic Testing & Emerging Technologies
Child–parent hypercholesterolemia (FH) screening is a practical and effective way of conducting population-based screening to identify the…
Already a member? Log in here
How Meaningful are Results of Testing a Drop of Blood?
From – Diagnostic Testing & Emerging Technologies
With Theranos’ recent announcement of its transition away from laboratory operations toward technology development…
Already a member? Log in here
Genetic Variants May Personalize Diabetes Care
...
Already a member? Log in here
Reanalyzing Exome Data Increases Understanding of Variant-Disease Associations
From – Diagnostic Testing & Emerging Technologies
Reanalysis of clinical exome data at a two- to three-year interval could result in an incremental 10 percent diagnostic yield…
Already a member? Log in here
Patients Prefer Web Access to Test Results
From – Diagnostic Testing & Emerging Technologies
Patients increasingly prefer to receive laboratory test results via password-protected websites and portals, according to…
Already a member? Log in here
Periodic Exome Reanalysis Yields New Diagnoses
...
Already a member? Log in here
Expanded, Panethnic Carrier Screening May Be More Effective
...
Already a member? Log in here
New Strategies Increase HCV Testing in Primary Care, ER and Linkages to Care
...
Already a member? Log in here
Mass Spec Receiving Broader Application
From – Diagnostic Testing & Emerging Technologies
Mass spectrometry (MS) is rapidly transitioning from specialized clinical testing—drugs of abuse confirmations, newborn screening, and steroid analysis—to being broadly applied throughout…
Already a member? Log in here
Molecular Autopsy Becoming Viable to Implement
...
Already a member? Log in here